Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AIDS and the eyes

D Sarraf1, J T Ernest

  • 1Department of Ophthalmology and Visual Science, University of Chicago, Illinois 60637, USA.

Lancet (London, England)
|August 24, 1996
PubMed
Summary
This summary is machine-generated.

Ocular complications affect 50-75% of adult patients with Acquired Immunodeficiency Syndrome (AIDS). Regular screening of Human Immunodeficiency Virus (HIV)-positive patients is crucial for early detection of vision-threatening conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is percutaneous medial hamstring myofascial lengthening as anatomically effective and safe as the open procedure?

Journal of children's orthopaedics·2017
Same author

Retinal pigment epithelial cell necroptosis in response to sodium iodate.

Cell death discovery·2016
Same author

OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy.

Eye (London, England)·2015
Same author

Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.

Eye (London, England)·2014
Same author

High-dose ranibizumab therapy for vascularized pigment epithelial detachment.

Eye (London, England)·2012
Same author

Mizuo--Nakamura phenomenon with a negative waveform ERG.

The British journal of ophthalmology·2009
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Immunology

Background:

  • Acquired Immunodeficiency Syndrome (AIDS) significantly impacts various organ systems.
  • Ocular manifestations are common in individuals with advanced Human Immunodeficiency Virus (HIV) infection.

Purpose of the Study:

  • To highlight the high prevalence of eye involvement in adult AIDS patients.
  • To emphasize the correlation between disease severity and ocular complications.
  • To advocate for routine ophthalmological screening in HIV-positive individuals.

Main Methods:

  • Retrospective analysis of patient data.
  • Clinical examination of ocular health.
  • Correlation of ocular findings with disease stage and CD4+ T-cell counts.

Related Experiment Videos

Main Results:

  • Ocular involvement observed in 50-75% of adult AIDS patients.
  • Higher incidence of eye disease in symptomatic HIV-positive patients compared to asymptomatic ones.
  • Increased frequency of ocular complications with greater disease severity.

Conclusions:

  • Early and regular screening for ocular disease is essential in HIV-positive patients.
  • Prompt identification of vision-threatening conditions can improve patient outcomes.
  • Ophthalmological monitoring is a critical component of comprehensive HIV/AIDS care.